Top Markets
Coin of the day
Modalis Therapeutics Corporation Modalis Therapeutics Corporation

Modalis Therapeutics Corporation

4883
Clasificación en acciones #29672
Modalis Therapeutics Corporation focuses on discovering and developing... Modalis Therapeutics Corporation focuses on discovering and developing treatments for severe genetic conditions. The company utilizes its proprietary CRISPR-GNDM technology to create therapies by controlling gene expression through the epigenetic modulation of specific genetic loci. Modalis also has a collaborative research agreement with JCR Pharmaceuticals Co., Ltd., aimed at assessing gene therapy drug delivery methods for the central nervous system (CNS), particularly for CNS-related disorders. Founded in 2016, the company was initially known as EdiGENE Corporation before changing its name to Modalis Therapeutics Corporation in August 2019. Its operations are based in Tokyo, Japan.
Precio por acción
$0.20877985
Capitalización bursátil
$20.11M
Cambio (1 día)
-3.03%
Cambio (1 año)
-66.13%
País
JP
Comercio Modalis Therapeutics Corporation (4883)

Categoría

Precio 4883 con Capital del mercado a B
Modalis Therapeutics Corporation Modalis Therapeutics Corporation
4883
$0.20877985
Capitalización de mercado de Modalis Therapeutics Corporation(4883)
Capitalización bursátil: $20.11M
A fecha de August 2026, Modalis Therapeutics Corporation tiene una capitalización de mercado de $20.11M. Esto convierte a Modalis Therapeutics Corporation en la 29672nd empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Modalis Therapeutics Corporation desde 2020 hasta 2026
4883 en comparación con los más populares 5 títulos stocks
Precio por 4883 Activo B Capital del mercado en B Resultados
Modalis Therapeutics Corporation Modalis Therapeutics Corporation
$55,085.19 $20.11M
$5.307T +26,384,243.64%
Modalis Therapeutics Corporation Modalis Therapeutics Corporation
$47,239.07 $20.11M
$4.551T +22,626,160.49%
Modalis Therapeutics Corporation Modalis Therapeutics Corporation
$43,124.55 $20.11M
$4.154T +20,655,414.99%
Modalis Therapeutics Corporation Modalis Therapeutics Corporation
$37,251.07 $20.11M
$3.589T +17,842,171.35%
Modalis Therapeutics Corporation Modalis Therapeutics Corporation
$29,032.79 $20.11M
$2.797T +13,905,836.15%